GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q1 2015. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $205,000 | -11.3% | 5,350 | 0.0% | 0.11% | -13.1% |
| Q3 2016 | $231,000 | -0.4% | 5,350 | 0.0% | 0.12% | +1.7% |
| Q2 2016 | $232,000 | +7.4% | 5,350 | 0.0% | 0.12% | +4.3% |
| Q1 2016 | $216,000 | -54.3% | 5,350 | -54.4% | 0.12% | -61.9% |
| Q4 2015 | $473,000 | -33.3% | 11,725 | -36.4% | 0.30% | -40.1% |
| Q3 2015 | $709,000 | -54.7% | 18,450 | -50.9% | 0.50% | -51.0% |
| Q2 2015 | $1,565,000 | -35.3% | 37,575 | -28.3% | 1.03% | -35.5% |
| Q1 2015 | $2,417,000 | +10.3% | 52,375 | +2.1% | 1.60% | +12.1% |
| Q4 2014 | $2,192,000 | +66.8% | 51,300 | +79.4% | 1.42% | +62.6% |
| Q3 2014 | $1,314,000 | +85.9% | 28,600 | +116.4% | 0.88% | +87.6% |
| Q2 2014 | $707,000 | -1.8% | 13,215 | -2.0% | 0.47% | -6.4% |
| Q1 2014 | $720,000 | -5.3% | 13,490 | -5.3% | 0.50% | -6.4% |
| Q4 2013 | $760,000 | – | 14,250 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
| Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
| Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
| Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
| P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
| Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
| Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
| Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
| Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
| JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |